【レポートの概要（一部）】
1. Report Overview
1.1 Overview of the Nanomedicine Industry and Market
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Main Questions Answered by this Analysis
1.5 Who Is This Study For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Some Associated Reports
1.9 About Visiongain
2. Introduction to Nanomedicine
2.1 Nanotechnology – Definition
2.2 Nanomedicine – Size Should Not be the Main Definition
2.3 Nanotechnology – Solutions and Improvements in Medicine
2.4 Nanomedicine – Types of Applications
2.4.1 Drug Delivery
2.4.2 Nanodrugs
2.4.2.1 Nanoparticles – Combinations of Three Dimensions
2.4.2.1.1 Liposomes
2.4.2.1.2 Polymers
2.4.2.1.3 Quantum Dots
2.4.2.1.4 Superparamagnetic Iron Oxide (SPIO)
2.4.2.1.5 Carbon Nanotubes
2.4.2.1.6 Carbon Nanoshells
2.4.2.2 Nanoparticle Functionalisation
2.4.2.2.1 Targeting
2.4.2.2.2 Surface Conjugation
2.4.2.2.3 Improved Bioavailability
2.4.2.2.4 Tunability
2.4.2.2.5 Controlled Release
2.4.3 Implants
2.4.4 Diagnostics
2.4.4.1 Diagnostic Tools
2.4.4.2 Medical Instruments
2.4.4.3 Imaging Tools
2.4.4.4 Theranostics
3. Global Nanomedicine Market, 2015-2025
3.1 Revenue Forecasts of Nanomedicine by Therapeutic Area
3.1.1 Forecast of Nanomedicine for Oncology 2015-2025
3.1.2 Forecast of Nanomedicine for Cardiovascular Uses 2015-2025
3.1.3 Forecast of Nanomedicine for Anti-inflammatory Uses 2015-2025
3.1.4 Forecast of Nanomedicine for Neurology 2015-2025
3.1.5 Forecast of Nanomedicine for Anti-Infective 2015-2025
3.1.6 Forecast of Nanomedicine for Other Therapeutic Areas 2015-2025
4. Nanomedicine Products – Commercial Outlooks from 2015
4.1 Nanomedicine Products – Segmentation
4.1.1 Nanomedicine Products in the Market – Revenue Potentials, 2015-2025
4.1.1.1 Abraxane (Celgene)
4.1.1.2 Doxil (Janssen)
4.1.1.3 Myocet (Teva Pharmaceuticals)
4.1.1.4 ONCASPAR (Baxalta)
4.1.1.5 Alimta (Eli Lilly)
4.1.1.6 Eligard (Sanofi)
4.1.1.7 DaunoXome (Galen)
4.1.1.8 Copaxone (Teva)
4.1.1.9 Rapamune (PF Prism)
4.1.1.10 Neulasta (Amgen)
4.1.1.11 Cimzia (UCB)
4.1.1.12 AmBisome (Astellas Pharma)
4.1.1.13 MIRCERA (Roche)
4.1.1.14 Pegasys (Roche)
4.1.1.15 Emend (Merck)
4.1.1.16 Renagel (Genzyme)
4.1.1.17 Ritalin (Novartis)
5. Leading National Markets, 2015-2025
5.1 Nanomedicine – Leading Markets, 2014
5.2 The US Nanomedicine Market, 2015-2025
5.3 The Japanese Nanomedicine Market, 2015-2025
5.4 The EU Nanomedicine Market, 2015-2025
5.5 The Asia-Pacific Nanomedicine Market, 2015-2025
5.6 Rest of the World Nanomedicine Market, 2015-2025
6. Profiles of Pharmaceutical Companies with Nanotechnology Related Applications
6.1 Sanofi
6.2 BIND Therapeutics
6.3 Merck
6.4 Pfizer
6.5 Cerulean Pharma
6.6 Selecta Biosciences
6.7 Nanobiotix
6.8 Magforce
6.9 Celgene
6.10 Celsion Corporation
6.11 Nanocarrier
7. Research & Development
7.1 Nanoparticles and Nano-enabled Drugs in the Pipeline
7.1.1 DermaVir (Genetic Immunity)
7.1.2 CRLX101 (Cerulean Pharma)
7.1.3 CPX-351 (Celator Pharma)
7.1.4 NC-6004 (NanoCarrier Co.)
7.1.5 NK-105 (Nippon Kayaku Co. Ltd.)
7.1.6 NK-012 (Nippon Kayaku Co. Ltd.)
7.1.7 SGT-53 (SynerGene Therapeutics)
7.1.8 BIND-014 (BIND Biosciences)
7.1.9 ThermoDox (Celsion)
7.1.10 ADI-PEG 20 (Polaris)
8. Qualitative Analysis of the Nanomedicine Market, 2015
8.1 Room for Improvement
8.1.1 Safety and Toxicology Often Yet to be Determined
8.1.2 Establishment of Structures and Collaborations
8.1.3 Regulatory – The Need for Clear Guidelines and Harmonization
9. Research Interviews, 2015
9.1 Dr Peter Wick, Empa, the Swiss Federal Laboratories for Materials Science and Technology
9.1.1 Connecting the Key Players in the Nanomedical Sector in Europe
9.1.2 Nanomedicine Industry in Europe – In Need of an Infrastructure
9.1.3 EU-NCL: Bridging the Major Gaps and Challenges
9.2 Dr Peter D. Suzdak, CEO, Rexahn Pharmaceuticals
9.2.1 Precision-Targeted Therapy – Revolutionizes Cancer Treatment
9.2.2 RX-21101 – Included in NCL’s Preclinical Characterization Program
9.2.3 Rexahn’s NPDCS Technology – Next Generation Approach to Chemotherapy
9.2.4 Rexahn’s Polymer-Drug Conjugate – Improves Efficacy and Reduces Side Effects
9.3 Dr Joost Holthuis, CEO, Cristal Therapeutics, Netherlands
9.3.1 Nanomedicine Industry in Europe
9.3.2 CriPec Based Nanomedicines – Overcome the Drawbacks of Conventional Therapies
9.3.3 CriPec Platform – All the Best Features in a Single System
9.3.4 CriPec Docetaxel – Lead Candidate Product
9.3.5 In Development – CriPec Actively Targeted Nanoparticles Platform
9.3.6 Competitive Advantage Can be Achieved Through Partnering of Parties
10. Conclusions of the Research and Analysis
10.1 Nanotechnology Holds Great Promise in Healthcare
10.2 More Research Needed to Establish Safety
10.3 Harmonization in Definition and Guidelines
【レポート販売概要】
■ タイトル：ナノメディシンの世界市場2015-2025■ 英文：Nanopharmaceutical Industry and Market: Companies, Products, R&D and Revenue Forecasts 2015-2025
■ 発行日：2015年9月
■ 調査会社：visiongain
■ 商品コード：VGAIN5100107
■ 調査対象地域：グローバル
- 世界の小型自動車用OEホイール市場【2015年1月更新版】This latest just-auto report edition offers a global review of the OE wheels sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE wheels market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies and prospects Market …
- EOR年報2016：増進回収法（EOR）完全ガイドブック• Do you need one definitive document that provides a comprehensive outlook for all aspects of enhanced oil recovery? • Do you need to know how the current oil price impacts EOR prospects? • Are you looking to find out which EOR technology is most likely to prevail: Gas, Chemical or Thermal EOR technologies? • Do you need revealing company market share data of the leading players for each EOR tech …
- 除菌濾過製品の世界市場：メンブランフィルター、カートリッジ・カプセル、シリンジフィルター、真空フィルター、濾過用漏斗、付属品The global sterile filtration market is expected to USD 7.46 Billion by 2020 from USD 4.00 Billion in 2015, at a CAGR of 12.4% between 2015 and 2020. The major drivers for the market include the increase in R&D spending, growth in the biopharmaceutical industry, growing demand for biopharmaceutical molecules, rising incidence of diabetes & kidney failure, and increasing purity requirements of the …
- 耳鼻咽喉科（ENT）用デバイスの世界市場2015-2022According to Stratistics MRC, ENT devices market is expected to grow from $9,100 million in 2015 to $14,785 million by 2022 at a CAGR of 7.2%. The major factors impacting ENT device market growth are increasing aging population and related disorders such as lower functioning levels of ear, nose, & throat and hearing loss. In addition, technological advancements, rising occurrence of chronic sinusi …
- 世界の子供服市場動向（2014-2018）TechNavio's analysts forecast the Global Children's Wear market to grow at a CAGR of 5.36 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing consumer spending on children's wear. The Global Children's Wear market has also been witnessing the increasing demand for luxury children's wear in developed economies. However, the increasing vendo …
- Gilenya (Multiple Sclerosis)：市場予測と分析（～2022）Gilenya (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Gilenya (Multiple Sclerosis) - Forecast and Market Analysis to 2022”. Multiple sclerosis (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervo …
- 軍事用ボディアーマー（防弾衣）の世界市場2017-2021ABSTRACTAbout Body Armor The global body armor market for military applications is expected to witness significant growth during the forecast period. One of the reasons for market growth is the increasing safety concerns for armed forces and the global presence of vendors offering a wide range of body armors. The market is also driven by increasing security threats across regions and advances in e …
- UCaaSの世界市場予測UCaaS is now becoming an indispensable tool for all forms of business communications, whether it is through video conferencing, teleconference, instant messaging, or by email. UCaaS is now a preferred method of collaboration in organizations. Currently, companies are investing heavily to delivery high quality video, voice, and conferencing collaboration services. Companies in the UC market are loo …
- ジシアンジアミドの世界市場2015Dicyandiamid (CAS 461-58-5) Market Research Report 2015 aims at providing comprehensive data on Dicyandiamid market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Dicyandiamid description, covers its application areas, manufacturing methods, patterns. It captures Dicyandiamid market trends, pays close attention to Dicyandiamid manufacturers and names …
- 3Dプリンター用パウダーの世界市場：金属粉末、プラスチック粉末、セラミック粉末The global 3D printing powder market is projected to reach USD 636.9 Million by 2020, at a CAGR of 24.4% from 2015 to 2020. The growth of the market is primarily driven by the expiry of key patents for powder-based additive manufacturing in 2014 and increasing investments in research & development of powder-based technology. 3D printing or additive manufacturing is majorly used in the aerospace & …
- 皮膚炎(Dermatitis)：世界の治験レビュー（2015年上半期版）Dermatitis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Dermatitis Global Clinical Trials Review, H1, 2015" provides an overview of Dermatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Dermatitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across t …
- 世界のカバーガラス市場動向（2012-2016）TechNavio's analysts forecast the Global Cover Glass market to grow at a CAGR of 21.8 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing adoption of mobile phones. The Global Cover Glass market has also been witnessing an increased number of collaborations among enterprises. However, high production costs could pose a challenge to the gro …
- Mobile Applications and Widgets: Portable Applications on Mobile Platforms, Fourth EditionMobile Applications and Widgets: Portable Applications on Mobile Platforms, Fourth Edition provides a complete understanding of the mobile software marketplace. The reader will learn about mobile applications from the inception and evolution of applications on mobile platforms, to current market trends. The state of the current market is defined through current market statistical data, financial a …
- データセンターSANの世界市場2016-2020About Data Center SAN SAN is a high-speed network of storage devices connected to the server. It provides block level data storage for applications running on networked servers. At the block level, it allows multiple server computers connect to one storage device. Simultaneous access to a particular storage within the storage device is not permitted in SAN systems. However, they allow a server to …
- グローバルにおける風力発電タービン受注動向20142014 Wind Turbine Order Intake - Siemens Leads the Market Due to Growth in Offshore Activity Summary Annual wind capacity additions are expected to reach a record high of 48 Gigawatts (GW) in 2014, having grown at a rate of 28% from 37.4 GW in 2013. Siemens, Vestas, GE, Gamesa and Acciona signed the largest volume of publically announced firm contracts for wind turbines in H1 2014 (until June 23). …
